Global Recreational Drugs Market

Recreational Drugs Comprehensive Study by Type (Depressants, Stimulants, Euphoriants, Hallucinogens, Inhalants), Sales Channel (B2B, B2C), End User (Men, Women) Players and Region - Global Market Outlook to 2026

Recreational Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Recreational Drugs?
Recreational drugs are chemical substances taken for enjoyment, or leisure purposes, rather than for medical reasons. Alcohol, tobacco, and caffeine can be classed as recreational drugs but are not covered in this leaflet. Recreational drugs are usually started to provide pleasure or improve life in some way. However, they can lead to addiction, health, and social problems, and to crime. Most are illegal, so their use comes with all the consequences of breaking the law.

The market study is broken down by Type (Depressants, Stimulants, Euphoriants, Hallucinogens and Inhalants) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Recreational Drugs market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Manitoba Harvest (Canada), Cw Hemp/cw Botanicals (United States), Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), MedMen (United States), Terra Tech Corp. (United States), Aphria Inc. (Canada), VIVO Cannabis Inc. (Canada), The Cronos Group (Canada), Medical Marijuana Inc. (United States), Stenocare (Denmark) and Tikun Olam (Israel) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Organigrams Holding Inc. (Canada), Cresco Labs (United States), Maricann Group Inc. (Canada), Indiva (Canada), Hexo Corp. (Canada), Ecofibre Limited (Australia), Curaleaf Holdings (United States), Harvest Health and Recreation (United States), Green Thumb Industries (United States) and TerrAscend Canada).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Recreational Drugs market by Type, Application and Region.

On the basis of geography, the market of Recreational Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channel, the sub-segment i.e. B2B will boost the Recreational Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Men will boost the Recreational Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Increase in R&D and Technological Innovation

Market Drivers
  • Growth in the Medical Applications of Recreational Drugs
  • Increase in Legalization of Recreational Drugs and Rise in Social Acceptance of Marijuana

Opportunities
  • Product Development via Research and Novel Product Delivery Solutions
  • Emergence of Recreational Drugs Legalization in the Asia Pacific

Restraints
  • Complex Regulatory Structure for the Usage of Recreational Drugs

Challenges
  • Intensive Energy Consumption and Maintaining Product Consistency for the Cultivation of Recreational Drugs
  • Myths Associated with Recreational Drugs


Key Target Audience
Recreational Drugs Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Depressants
  • Stimulants
  • Euphoriants
  • Hallucinogens
  • Inhalants
By Sales Channel
  • B2B
  • B2C

By End User
  • Men
  • Women

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in the Medical Applications of Recreational Drugs
      • 3.2.2. Increase in Legalization of Recreational Drugs and Rise in Social Acceptance of Marijuana
    • 3.3. Market Challenges
      • 3.3.1. Intensive Energy Consumption and Maintaining Product Consistency for the Cultivation of Recreational Drugs
      • 3.3.2. Myths Associated with Recreational Drugs
    • 3.4. Market Trends
      • 3.4.1. Increase in R&D and Technological Innovation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Recreational Drugs, by Type, Sales Channel, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Recreational Drugs (Value)
      • 5.2.1. Global Recreational Drugs by: Type (Value)
        • 5.2.1.1. Depressants
        • 5.2.1.2. Stimulants
        • 5.2.1.3. Euphoriants
        • 5.2.1.4. Hallucinogens
        • 5.2.1.5. Inhalants
      • 5.2.2. Global Recreational Drugs by: Sales Channel (Value)
        • 5.2.2.1. B2B
        • 5.2.2.2. B2C
      • 5.2.3. Global Recreational Drugs by: End User (Value)
        • 5.2.3.1. Men
        • 5.2.3.2. Women
      • 5.2.4. Global Recreational Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Recreational Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Manitoba Harvest (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cw Hemp/cw Botanicals (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Canopy Growth Corporation (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aurora Cannabis Inc. (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. MedMen (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Terra Tech Corp. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Aphria Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. VIVO Cannabis Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The Cronos Group (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Medical Marijuana Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Stenocare (Denmark)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Tikun Olam (Israel)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Recreational Drugs Sale, by Type, Sales Channel, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Recreational Drugs (Value)
      • 7.2.1. Global Recreational Drugs by: Type (Value)
        • 7.2.1.1. Depressants
        • 7.2.1.2. Stimulants
        • 7.2.1.3. Euphoriants
        • 7.2.1.4. Hallucinogens
        • 7.2.1.5. Inhalants
      • 7.2.2. Global Recreational Drugs by: Sales Channel (Value)
        • 7.2.2.1. B2B
        • 7.2.2.2. B2C
      • 7.2.3. Global Recreational Drugs by: End User (Value)
        • 7.2.3.1. Men
        • 7.2.3.2. Women
      • 7.2.4. Global Recreational Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Recreational Drugs: by Type(USD Million)
  • Table 2. Recreational Drugs Depressants , by Region USD Million (2015-2020)
  • Table 3. Recreational Drugs Stimulants , by Region USD Million (2015-2020)
  • Table 4. Recreational Drugs Euphoriants , by Region USD Million (2015-2020)
  • Table 5. Recreational Drugs Hallucinogens , by Region USD Million (2015-2020)
  • Table 6. Recreational Drugs Inhalants , by Region USD Million (2015-2020)
  • Table 7. Recreational Drugs: by Sales Channel(USD Million)
  • Table 8. Recreational Drugs B2B , by Region USD Million (2015-2020)
  • Table 9. Recreational Drugs B2C , by Region USD Million (2015-2020)
  • Table 10. Recreational Drugs: by End User(USD Million)
  • Table 11. Recreational Drugs Men , by Region USD Million (2015-2020)
  • Table 12. Recreational Drugs Women , by Region USD Million (2015-2020)
  • Table 13. South America Recreational Drugs, by Country USD Million (2015-2020)
  • Table 14. South America Recreational Drugs, by Type USD Million (2015-2020)
  • Table 15. South America Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 16. South America Recreational Drugs, by End User USD Million (2015-2020)
  • Table 17. Brazil Recreational Drugs, by Type USD Million (2015-2020)
  • Table 18. Brazil Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 19. Brazil Recreational Drugs, by End User USD Million (2015-2020)
  • Table 20. Argentina Recreational Drugs, by Type USD Million (2015-2020)
  • Table 21. Argentina Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 22. Argentina Recreational Drugs, by End User USD Million (2015-2020)
  • Table 23. Rest of South America Recreational Drugs, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 25. Rest of South America Recreational Drugs, by End User USD Million (2015-2020)
  • Table 26. Asia Pacific Recreational Drugs, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Recreational Drugs, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 29. Asia Pacific Recreational Drugs, by End User USD Million (2015-2020)
  • Table 30. China Recreational Drugs, by Type USD Million (2015-2020)
  • Table 31. China Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 32. China Recreational Drugs, by End User USD Million (2015-2020)
  • Table 33. Japan Recreational Drugs, by Type USD Million (2015-2020)
  • Table 34. Japan Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 35. Japan Recreational Drugs, by End User USD Million (2015-2020)
  • Table 36. India Recreational Drugs, by Type USD Million (2015-2020)
  • Table 37. India Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 38. India Recreational Drugs, by End User USD Million (2015-2020)
  • Table 39. South Korea Recreational Drugs, by Type USD Million (2015-2020)
  • Table 40. South Korea Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 41. South Korea Recreational Drugs, by End User USD Million (2015-2020)
  • Table 42. Taiwan Recreational Drugs, by Type USD Million (2015-2020)
  • Table 43. Taiwan Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 44. Taiwan Recreational Drugs, by End User USD Million (2015-2020)
  • Table 45. Australia Recreational Drugs, by Type USD Million (2015-2020)
  • Table 46. Australia Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 47. Australia Recreational Drugs, by End User USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Recreational Drugs, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Recreational Drugs, by End User USD Million (2015-2020)
  • Table 51. Europe Recreational Drugs, by Country USD Million (2015-2020)
  • Table 52. Europe Recreational Drugs, by Type USD Million (2015-2020)
  • Table 53. Europe Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 54. Europe Recreational Drugs, by End User USD Million (2015-2020)
  • Table 55. Germany Recreational Drugs, by Type USD Million (2015-2020)
  • Table 56. Germany Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 57. Germany Recreational Drugs, by End User USD Million (2015-2020)
  • Table 58. France Recreational Drugs, by Type USD Million (2015-2020)
  • Table 59. France Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 60. France Recreational Drugs, by End User USD Million (2015-2020)
  • Table 61. Italy Recreational Drugs, by Type USD Million (2015-2020)
  • Table 62. Italy Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 63. Italy Recreational Drugs, by End User USD Million (2015-2020)
  • Table 64. United Kingdom Recreational Drugs, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 66. United Kingdom Recreational Drugs, by End User USD Million (2015-2020)
  • Table 67. Netherlands Recreational Drugs, by Type USD Million (2015-2020)
  • Table 68. Netherlands Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 69. Netherlands Recreational Drugs, by End User USD Million (2015-2020)
  • Table 70. Rest of Europe Recreational Drugs, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 72. Rest of Europe Recreational Drugs, by End User USD Million (2015-2020)
  • Table 73. MEA Recreational Drugs, by Country USD Million (2015-2020)
  • Table 74. MEA Recreational Drugs, by Type USD Million (2015-2020)
  • Table 75. MEA Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 76. MEA Recreational Drugs, by End User USD Million (2015-2020)
  • Table 77. Middle East Recreational Drugs, by Type USD Million (2015-2020)
  • Table 78. Middle East Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 79. Middle East Recreational Drugs, by End User USD Million (2015-2020)
  • Table 80. Africa Recreational Drugs, by Type USD Million (2015-2020)
  • Table 81. Africa Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 82. Africa Recreational Drugs, by End User USD Million (2015-2020)
  • Table 83. North America Recreational Drugs, by Country USD Million (2015-2020)
  • Table 84. North America Recreational Drugs, by Type USD Million (2015-2020)
  • Table 85. North America Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 86. North America Recreational Drugs, by End User USD Million (2015-2020)
  • Table 87. United States Recreational Drugs, by Type USD Million (2015-2020)
  • Table 88. United States Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 89. United States Recreational Drugs, by End User USD Million (2015-2020)
  • Table 90. Canada Recreational Drugs, by Type USD Million (2015-2020)
  • Table 91. Canada Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 92. Canada Recreational Drugs, by End User USD Million (2015-2020)
  • Table 93. Mexico Recreational Drugs, by Type USD Million (2015-2020)
  • Table 94. Mexico Recreational Drugs, by Sales Channel USD Million (2015-2020)
  • Table 95. Mexico Recreational Drugs, by End User USD Million (2015-2020)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Recreational Drugs: by Type(USD Million)
  • Table 109. Recreational Drugs Depressants , by Region USD Million (2021-2026)
  • Table 110. Recreational Drugs Stimulants , by Region USD Million (2021-2026)
  • Table 111. Recreational Drugs Euphoriants , by Region USD Million (2021-2026)
  • Table 112. Recreational Drugs Hallucinogens , by Region USD Million (2021-2026)
  • Table 113. Recreational Drugs Inhalants , by Region USD Million (2021-2026)
  • Table 114. Recreational Drugs: by Sales Channel(USD Million)
  • Table 115. Recreational Drugs B2B , by Region USD Million (2021-2026)
  • Table 116. Recreational Drugs B2C , by Region USD Million (2021-2026)
  • Table 117. Recreational Drugs: by End User(USD Million)
  • Table 118. Recreational Drugs Men , by Region USD Million (2021-2026)
  • Table 119. Recreational Drugs Women , by Region USD Million (2021-2026)
  • Table 120. South America Recreational Drugs, by Country USD Million (2021-2026)
  • Table 121. South America Recreational Drugs, by Type USD Million (2021-2026)
  • Table 122. South America Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 123. South America Recreational Drugs, by End User USD Million (2021-2026)
  • Table 124. Brazil Recreational Drugs, by Type USD Million (2021-2026)
  • Table 125. Brazil Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 126. Brazil Recreational Drugs, by End User USD Million (2021-2026)
  • Table 127. Argentina Recreational Drugs, by Type USD Million (2021-2026)
  • Table 128. Argentina Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 129. Argentina Recreational Drugs, by End User USD Million (2021-2026)
  • Table 130. Rest of South America Recreational Drugs, by Type USD Million (2021-2026)
  • Table 131. Rest of South America Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 132. Rest of South America Recreational Drugs, by End User USD Million (2021-2026)
  • Table 133. Asia Pacific Recreational Drugs, by Country USD Million (2021-2026)
  • Table 134. Asia Pacific Recreational Drugs, by Type USD Million (2021-2026)
  • Table 135. Asia Pacific Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 136. Asia Pacific Recreational Drugs, by End User USD Million (2021-2026)
  • Table 137. China Recreational Drugs, by Type USD Million (2021-2026)
  • Table 138. China Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 139. China Recreational Drugs, by End User USD Million (2021-2026)
  • Table 140. Japan Recreational Drugs, by Type USD Million (2021-2026)
  • Table 141. Japan Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 142. Japan Recreational Drugs, by End User USD Million (2021-2026)
  • Table 143. India Recreational Drugs, by Type USD Million (2021-2026)
  • Table 144. India Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 145. India Recreational Drugs, by End User USD Million (2021-2026)
  • Table 146. South Korea Recreational Drugs, by Type USD Million (2021-2026)
  • Table 147. South Korea Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 148. South Korea Recreational Drugs, by End User USD Million (2021-2026)
  • Table 149. Taiwan Recreational Drugs, by Type USD Million (2021-2026)
  • Table 150. Taiwan Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 151. Taiwan Recreational Drugs, by End User USD Million (2021-2026)
  • Table 152. Australia Recreational Drugs, by Type USD Million (2021-2026)
  • Table 153. Australia Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 154. Australia Recreational Drugs, by End User USD Million (2021-2026)
  • Table 155. Rest of Asia-Pacific Recreational Drugs, by Type USD Million (2021-2026)
  • Table 156. Rest of Asia-Pacific Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Recreational Drugs, by End User USD Million (2021-2026)
  • Table 158. Europe Recreational Drugs, by Country USD Million (2021-2026)
  • Table 159. Europe Recreational Drugs, by Type USD Million (2021-2026)
  • Table 160. Europe Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 161. Europe Recreational Drugs, by End User USD Million (2021-2026)
  • Table 162. Germany Recreational Drugs, by Type USD Million (2021-2026)
  • Table 163. Germany Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 164. Germany Recreational Drugs, by End User USD Million (2021-2026)
  • Table 165. France Recreational Drugs, by Type USD Million (2021-2026)
  • Table 166. France Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 167. France Recreational Drugs, by End User USD Million (2021-2026)
  • Table 168. Italy Recreational Drugs, by Type USD Million (2021-2026)
  • Table 169. Italy Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 170. Italy Recreational Drugs, by End User USD Million (2021-2026)
  • Table 171. United Kingdom Recreational Drugs, by Type USD Million (2021-2026)
  • Table 172. United Kingdom Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 173. United Kingdom Recreational Drugs, by End User USD Million (2021-2026)
  • Table 174. Netherlands Recreational Drugs, by Type USD Million (2021-2026)
  • Table 175. Netherlands Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 176. Netherlands Recreational Drugs, by End User USD Million (2021-2026)
  • Table 177. Rest of Europe Recreational Drugs, by Type USD Million (2021-2026)
  • Table 178. Rest of Europe Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 179. Rest of Europe Recreational Drugs, by End User USD Million (2021-2026)
  • Table 180. MEA Recreational Drugs, by Country USD Million (2021-2026)
  • Table 181. MEA Recreational Drugs, by Type USD Million (2021-2026)
  • Table 182. MEA Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 183. MEA Recreational Drugs, by End User USD Million (2021-2026)
  • Table 184. Middle East Recreational Drugs, by Type USD Million (2021-2026)
  • Table 185. Middle East Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 186. Middle East Recreational Drugs, by End User USD Million (2021-2026)
  • Table 187. Africa Recreational Drugs, by Type USD Million (2021-2026)
  • Table 188. Africa Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 189. Africa Recreational Drugs, by End User USD Million (2021-2026)
  • Table 190. North America Recreational Drugs, by Country USD Million (2021-2026)
  • Table 191. North America Recreational Drugs, by Type USD Million (2021-2026)
  • Table 192. North America Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 193. North America Recreational Drugs, by End User USD Million (2021-2026)
  • Table 194. United States Recreational Drugs, by Type USD Million (2021-2026)
  • Table 195. United States Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 196. United States Recreational Drugs, by End User USD Million (2021-2026)
  • Table 197. Canada Recreational Drugs, by Type USD Million (2021-2026)
  • Table 198. Canada Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 199. Canada Recreational Drugs, by End User USD Million (2021-2026)
  • Table 200. Mexico Recreational Drugs, by Type USD Million (2021-2026)
  • Table 201. Mexico Recreational Drugs, by Sales Channel USD Million (2021-2026)
  • Table 202. Mexico Recreational Drugs, by End User USD Million (2021-2026)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Recreational Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Recreational Drugs: by Sales Channel USD Million (2015-2020)
  • Figure 6. Global Recreational Drugs: by End User USD Million (2015-2020)
  • Figure 7. South America Recreational Drugs Share (%), by Country
  • Figure 8. Asia Pacific Recreational Drugs Share (%), by Country
  • Figure 9. Europe Recreational Drugs Share (%), by Country
  • Figure 10. MEA Recreational Drugs Share (%), by Country
  • Figure 11. North America Recreational Drugs Share (%), by Country
  • Figure 12. Global Recreational Drugs share by Players 2020 (%)
  • Figure 13. Global Recreational Drugs share by Players (Top 3) 2020(%)
  • Figure 14. Global Recreational Drugs share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Manitoba Harvest (Canada) Revenue, Net Income and Gross profit
  • Figure 17. Manitoba Harvest (Canada) Revenue: by Geography 2020
  • Figure 18. Cw Hemp/cw Botanicals (United States) Revenue, Net Income and Gross profit
  • Figure 19. Cw Hemp/cw Botanicals (United States) Revenue: by Geography 2020
  • Figure 20. Canopy Growth Corporation (Canada) Revenue, Net Income and Gross profit
  • Figure 21. Canopy Growth Corporation (Canada) Revenue: by Geography 2020
  • Figure 22. Aurora Cannabis Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Aurora Cannabis Inc. (Canada) Revenue: by Geography 2020
  • Figure 24. MedMen (United States) Revenue, Net Income and Gross profit
  • Figure 25. MedMen (United States) Revenue: by Geography 2020
  • Figure 26. Terra Tech Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Terra Tech Corp. (United States) Revenue: by Geography 2020
  • Figure 28. Aphria Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 29. Aphria Inc. (Canada) Revenue: by Geography 2020
  • Figure 30. VIVO Cannabis Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 31. VIVO Cannabis Inc. (Canada) Revenue: by Geography 2020
  • Figure 32. The Cronos Group (Canada) Revenue, Net Income and Gross profit
  • Figure 33. The Cronos Group (Canada) Revenue: by Geography 2020
  • Figure 34. Medical Marijuana Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Medical Marijuana Inc. (United States) Revenue: by Geography 2020
  • Figure 36. Stenocare (Denmark) Revenue, Net Income and Gross profit
  • Figure 37. Stenocare (Denmark) Revenue: by Geography 2020
  • Figure 38. Tikun Olam (Israel) Revenue, Net Income and Gross profit
  • Figure 39. Tikun Olam (Israel) Revenue: by Geography 2020
  • Figure 40. Global Recreational Drugs: by Type USD Million (2021-2026)
  • Figure 41. Global Recreational Drugs: by Sales Channel USD Million (2021-2026)
  • Figure 42. Global Recreational Drugs: by End User USD Million (2021-2026)
  • Figure 43. South America Recreational Drugs Share (%), by Country
  • Figure 44. Asia Pacific Recreational Drugs Share (%), by Country
  • Figure 45. Europe Recreational Drugs Share (%), by Country
  • Figure 46. MEA Recreational Drugs Share (%), by Country
  • Figure 47. North America Recreational Drugs Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Manitoba Harvest (Canada)
  • Cw Hemp/cw Botanicals (United States)
  • Canopy Growth Corporation (Canada)
  • Aurora Cannabis Inc. (Canada)
  • MedMen (United States)
  • Terra Tech Corp. (United States)
  • Aphria Inc. (Canada)
  • VIVO Cannabis Inc. (Canada)
  • The Cronos Group (Canada)
  • Medical Marijuana Inc. (United States)
  • Stenocare (Denmark)
  • Tikun Olam (Israel)
Additional players considered in the study are as follows:
Organigrams Holding Inc. (Canada) , Cresco Labs (United States) , Maricann Group Inc. (Canada) , Indiva (Canada) , Hexo Corp. (Canada) , Ecofibre Limited (Australia) , Curaleaf Holdings (United States) , Harvest Health and Recreation (United States) , Green Thumb Industries (United States) , TerrAscend Canada)
Select User Access Type

Key Highlights of Report


Feb 2021 228 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Recreational Drugs Market Quantitative research analysis
Global Recreational Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Manitoba Harvest (Canada), Cw Hemp/cw Botanicals (United States), Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), MedMen (United States), Terra Tech Corp. (United States), Aphria Inc. (Canada), VIVO Cannabis Inc. (Canada), The Cronos Group (Canada), Medical Marijuana Inc. (United States), Stenocare (Denmark) and Tikun Olam (Israel) etc.
Analysts at AMA estimates Recreational Drugs Market to reach USDXXX by 2026.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Recreational Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Mirtazapine Tablets Comprehensive Study by Type (Immediate-Release Tablet, Orally Disintegrating Tablet), Application (Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder...
$ 3750
Cabergoline Tablets Comprehensive Study by Application (Hyperprolactinemia, Parkinson's Disease, Valvular Disorders), Patient Age (Children (above 17 years), Adults (18-60), Older Adults (60 above)),...
$ 3450
Josamycin Drugs Comprehensive Study by Type (Coated Tablets (500 mg), Dispersible Tablets (1 G), Suspension (in 5 ml - 150 mg)), Application (Upper & Lower Respiratory Tract Infection, Diphtheria, Sc...
$ 3650
Escitalopram tablet Comprehensive Study by Application (Treatment, Depression, Anxiety Disorder, Others, Research Studies), Patient Age (Adolescent (12- 17 years), Adults (18 above)), Dosage (5mg, 10...
$ 3500
Antineoplastic Interferon Drug Comprehensive Study by Type (Alpha Interferon, Beta Interferon, Gamma Interferon), Application (Angioblastoma, Chronic Myelogenous Leukemia, Renal Cell Carcinoma, Hepat...
$ 3650
Klinefelter syndrome Comprehensive Study by Treatment (Testosterone Replacement Therapy, Fertility Treatment, Breast Tissue Removal, Others), End User (Hospital and Clinics, Ambulatory Surgeries, Med...
$ 3450